About Linearis
Linearis is a venture capital firm founded in 2023. It is primarily based out of Quebec City, Canada. As of Feb 2025, Linearis has invested in 2 companies. It primarily invests in Series B round in Canada based startups. Its investments are spread across a wide range of sectors from Life Sciences to High Tech and HealthTech. Most recently it participated in the $***** Series B round of Feldan A lot of funds co-invest with Linearis, with names like Polaris Partners sharing a substantial percentage of its portfolio. Linearis has team of 5 people including 1 partners.Key Metrics
Team Members
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A & Series B
Linearis' List of All Investments
Linearis has a portfolio of 2 companies. Their most notable investments are in Noetik and Feldan.Their portfolio spans across Canada and United States. They have invested in Life Sciences, High Tech, HealthTech, across Series A, Series B stages. Here is the list of all investments by Linearis:
1. Noetik
Developer of AI-driven platform for cancer immunotherapy discovery and development. It leverages advanced machine learning to discover and develop cancer immunotherapies. The company uses AI to achieve what humans cannot do in the realm of tumor-immune interaction analysis. It combines self-supervised learning with human multimodal data generation to create foundation models for cell and tissue biology, driving therapeutic development.
Key facts about Noetik
- Founded Year: 2022
- Location: San Francisco (United States)
- Stage: Series A
- Total Funding till date: $62M
- Employee Count: 47 as on Apr 30, 2026
- Investors: EPIC Ventures, Khosla Ventures and 19 Others
- Latest Funding Round: Series A, Jul 31, 2024, $*****
- Highlight: Editors' Pick
2. Feldan
Feldan is developing regenerative medicine therapeutic applications based on Feldan’s proprietary technology. The company has developed Feldan Shuttle, a protein-based technology platform that directly delivers proteins – such as nucleases or transcription factors - inside cells to specific cellular compartments. The Shuttle can overcome obstacles faced by nucleic acid delivery for therapeutic use by decreasing the regulatory process and accelerating the translation of discoveries into clinical applications. The Shuttle also allows enables the development of in-house medical applications as well as in collaboration with partners.
Key facts about Feldan
- Founded Year: 2007
- Location: Quebec City (Canada)
- Stage: Series B
- Total Funding till date: $52.9M
- Employee Count: 42 as on Jun 18, 2025
- Investors: Cystic Fibrosis Foundation, Genesys Capital and 12 Others
- Latest Funding Round: Series B, Apr 16, 2025, $*****
- Highlight: Editors' Pick
Linearis' Year-on-Year Investment Trends
Linearis has invested in Feldan in 2025 and Noetik in 2024. In 2025, it made 1 investment. Its most recent first time investment was in Feldan.Linearis' Investments by Stage
Linearis has made 1 investment in Series A stage with an average round size of $40M and 1 investment in Series B stage.Linearis' Investments by Sector
Linearis has a diverse portfolio, with companies operating in the Life Sciences, Artificial Intelligence - Industry Applications, HealthTech and High Tech. Notably, it has invested in 2 Enterprise (B2B) companies, 2 Tech companies and 1 AI-Native company.Sector | No. of Investments |
|---|---|
Life Sciences | 2 |
Artificial Intelligence - Industry Applications | 1 |
HealthTech | 1 |
High Tech | 1 |
Note: We have considered here, only first round of investments
Linearis' Investments by Geography
Linearis has made most investments in Canada (1), followed by United States where it has made 1 investment.Linearis' recent investments
Linearis has not made any investment in 2026 so far.Here are the most recent investments by Linearis:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Feb 18, 2025 | Canada | Series B | 8011 | ||
Jul 31, 2024 | United States | Series A | 7385 | [+14] |
Team profile of Linearis
Linearis has a team of 5 members including 1 Partner and 1 Principal located in United States and Quebec. Linearis' team does not sit on the board of any company as of now.Co-investors of Linearis
Over the past 2 years, 32 investors have co-invested in Linearis's portfolio companies. This includes funds and angels.
- Invested before Linearis: DCVC, Zetta Venture Partners and 20 others have invested in rounds before Linearis. There is 1 company where DCVC has invested before Linearis and 1 company where Zetta Venture Partners has invested before Linearis.
- Top Co-investors of Linearis: 9 investors entered a company along with Linearis. These include investors like Polaris Partners (1 company).
- Invested after Linearis: Zynext Ventures (1 company) is the only investor which has invested in Linearis's portfolio after their investments.
Recent News related to Linearis
•
•
•
Noetik: AI-Based Biotech Company Raises $40 Million (Series A) To Develop Cancer TherapeuticsPulse 2.0•Sep 01, 2024•Noetik, Khosla Ventures, Wittington Ventures, Breakout Ventures and 10 others
•
Noetik raises $40M Series A to advance AI ambitions in cancer — with an unlikely lead investorEndPoints News•Aug 28, 2024•Noetik, Polaris Partners, Khosla Ventures, Wittington Ventures and 10 others
•
Linearis Labs Opens Lab Formerly Occupied by MedicagoContract Pharma•Nov 30, 2023•Linearis, Medicago
